Close
A stepping stone to becoming future leaders in MND research

A stepping stone to becoming future leaders in MND research

Reading Time: 6 minutes MND is a very complex disease and collaboration within the research community is key to building on our current understanding of the disease biology and finding effective treatments. The MND Association recognises the importance of expanding the dedicated MND research workforce, as well as supporting those who are already working in the field. To fund…

Cannabis-based products for medicinal use

Reading Time: 7 minutes In November 2018 the Home Office released a draft Guideline scope for Cannabis-based products for medicinal use in which they announced that specialist doctors (like consultant neurologists) on the Special Register of the General Medical Council will be able to prescribe cannabis-based medicinal products to some patients. Before this, the only cannabis-based medicines licensed for…

Understanding more about GM604

Reading Time: 3 minutes The MND Association’s Director of Research, Brian Dickie explains more about ‘GM6’, also known as ‘GM604’, a drug in development by an American pharmaceutical company Genervon. The Association funds a wide range of research that leads to new understanding and treatments, which may one day, bring us closer to a cure for MND. We are hopeful…

Unproven treatments: Have you really got nothing to lose by trying it?

Reading Time: 4 minutes The only ‘proven’ treatment to slow the progression of MND is Riluzole. There are, however, many organisations offering expensive ‘unproven’ and ‘alternative’ treatments for MND. We have worked with the organisation Sense about Science to help produce their ‘I’ve got nothing to lose by trying it’ information booklet so that people living with MND can…